MENU
HELX
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

Franklin Genomic Advancements ETF (HELX) Ownership - Who owns Franklin Genomic Advancements ETF?

The investment seeks capital appreciation... Show more

Category: #Health

Profile

Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
13794923.00
Fund Existence
over 5 years
Turnover
32.60
Capitalization
N/A
Yield
N/A
Total Expense Ratio
0.50
Investment Style
N/A
Risk (Beta)
1.16

Fundamentals

HELX
Net Assets
13.8M
Yield
0.00
Fund Existence
over 5 years
Total Expense Ratio
0.50
Turnover
32.60
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.16
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.50
Assets in Top Ten Holdings
4.12M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
13.8M
Fund Type
ETF
Index Fund
No
Management Fee
0.50
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
67.00
Number of Net Holdings
67.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
38.81%
Gain YTD
-4.183
View a ticker or compare two or three
HELX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com